Calcitonin gene-related peptide promotes differentiation, but not survival, of rat mesencephalic dopaminergic neurons in vitro

Neuroscience

Volumn 86, Issue 4, 1998, Pages 1165-1172

  Burvenich S ^a   Unsicker, K ^a   Krieglstein, K ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cell culture; Dopamine uptake; Dopaminergic neuron development; Fibroblast growth factor 2; Growth associated protein 43

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; FIBROBLAST GROWTH FACTOR 2;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; MESENCEPHALON; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NEUROTRANSMITTER UPTAKE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; DOPAMINE; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; NEURONS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0032543790     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00038-4     Document Type: Article

References (32)

1. Alexi T., Hefti F. Trophic actions of transforming growth-factor-alpha on mesencephalic dopaminergic neurons developing in culture. Neuroscience. 55:1993;903-918.
2. Amara S. G., Jonas V., Rosenfeld M. G., Ong E. S., Evans R. M. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature. 298:1982;238-244.
3. Amara S. G., Arriya J. L., Leff S. E., Swanson L. W., Evans R. M., Rosenfeld M. G. Expression in brain of a messenger RNA encoding a novel peptide homologous to calcitonin gene-related peptide. Science. 229:1985;1094-1097.
4. Amara S. G., Kuhar M. J. Neurotransmitter transporters: recent progress. A. Rev. Neurosci. 16:1993;73-93.
5. Beck K. D. Functions of brain-derived neurotrophic factor, insulin-like growth factor-1 and basic fibroblast growth factor in the development and maintenance of dopaminergic neurons. Prog. Neurobiol. 44:1994;497-516.
6. Denis-Donini S. Expression of dopaminergic phenotypes in the mouse olfactory bulb induced by the calcitonin gene-related peptide. Nature. 339:1989;701-703.
7. Denis-Donini S., Chini B., Vitadello M. Developmentally regulated expression of CGRP in the mouse olfactory pathway. Eur. J. Neurosci. 5:1993;648-656.
8. Engele J., Bohn M. C. The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia. J. Neurosci. 11:1991;3070-3078.
9. Engele J., Franke B. Effects of cell line-derived neurotrophic factor (GDNF) on dopaminergic neurons require concurrent activation of cAMP-dependent signaling pathways. Cell Tiss. Res. 286:1996;235-240.
10. Foster G. A., Schultzberg M., Goldstein M., Hökfelt T. Ontogeny of phenylethanolamine N-methyltransferase- and tyrosine hydroxylase-like immunoreactivity in the presumptive adrenaline neurons of the foetal rat central nervous system. J. comp. Neurol. 236:1985;341-381.
11. Goltzmann D., Mitchell J. Interaction of calcitonin and calcitonin gene-related peptide at receptor sites in target tissues. Science. 227:1985;1343-1345.
12. +-induced degeneration. J. Neurosci. Res. 32:1992;190-201.
13. Heldin C.-H. Dimerization of cell surface receptors in signal transduction. Cell. 80:1995;213-223.
14. +. J. neural Transm., Suppl. 46:1995;217-228.
15. Hynes M., Puolsen K., Tessier-Lavigne M., Rosenthal A. Control of neuronal diversity by the floor plate: contact-mediated induction of midbrain dopaminergic neurons. Cell. 80:1995;95-101.
16. Hynes M., Porter J. A., Chiang C., Chang D., Tessier-Lavigne M., Beachy P. A., Rosenthal A. Induction of midbrain dopaminergic neurons by sonic hedgehog. Neuron. 15:1995;35-44.
17. Karlsbeek A., Voorn P. and Buijs R. M. (1992) Development of dopamine-containing systems in the CNS. In Handbook of Chemical Neuroanatomy, Vol. 10: Ontogeny of transmitters and peptides in the CNS (eds Björklund A. et al.), pp. 63-112. Elsevier, Amsterdam.
18. Knusel B., Michel B. B., Schwaber J. S., Hefti F. Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. J. Neurosci. 10:1990;558-570.
19. + toxicity. Eur. molec. Biol. Org. J. 14:1995;736-742.
20. Krieglstein K., Maysinger D., Unsicker K. The survival of mesencephalic dopaminergic neurons to the neurotrophins BDNF and NT-4 requires priming with serum: comparison with members of the TGF-β superfamily and characterization of the serum-free culture system. J. neural Transm., Suppl. 47:1996;247-258.
21. Lohof A. M., Quillan M., Dan Y., Poo M.-M. Asymmetric modulation of cytosolic cAMP activity induces growth cone turning. J. Neurosci. 12:1992;1253-1261.
22. Michel P., Agid Y. Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons. J. Neurochem. 67:1996;1633-1642.
23. Richter-Landsberg C., Jastorff B. The role of cAMP in nerve growth factor-promoted neurite outgrowth in PC12 cells. J. Cell Biol. 102:1986;821-829.
24. Rosenfeld M. G., Mermod J.-J., Amara S. G., Swanson L. W., Sawchenko P. E., Rivier J., Vale W. W., Evans R. M. Production of a novel neuropeptide encoded by the calcitonin gene via tissue specific RNA processing. Nature. 304:1983;129-135.
25. Rydel R. E., Greene L. A. cAMP analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor. Proc. natn. Acad. Sci. U.S.A. 85:1988;1257-1261.
26. Skofitsch G. and Jacobowitz D. M. (1992) Calcitonin- and calcitonin gene-related peptide: receptor binding sites in the central nervous system. In Handbook of Chemical Neuroanatomy, Vol. 11: Neuropeptide Receptors in the CNS (eds Björklund A. et al.), pp. 97-144. Elsevier, Amsterdam.
27. Suhr S. T., Gage F. H. Gene therapy of neurologic disease. Archs Neurol. 50:1993;1252-1268.
28. Unsicker K. Growth factors in Parkinson's disease. Prog. Growth Factor Res. 5:1994;73-87.
29. Unsicker K., Suter-Crazzolara C. and Krieglstein K. (1996) Growth factor function in the development and maintenance of midbrain dopaminergic neurons: concepts, facts and prospects for TGF-β. In Growth Factors as Drugs for Neurological and Sensory Disorders (eds Bock G. R. and Goode J. A.), Ciba Foundation Symposium 196, pp. 70-84. John Wiley, Chichester.
30. Van Lookeren-Campagne M., Dotti C. G., Verkleij A. J., Gispen W. H., Oestreicher A. B. Redistribution of B-50/growth-associated protein 43 during differentiation and maturation of rat hippocampal neurons in vitro. Neuroscience. 51:1992;601-619.
31. Villa I., Colangelo A. M., Vescovi A. L., Gritti A., Schinelli S., Pagani F., Guidobono F. Differential effects of CGRP on adenylyl cyclase in adult and embryonic rat brains. NeuroReport. 5:1994;2489-2492.
32. Zheng J. Q., Zheng Z., Poo M.-M. Long-range signaling in growing neurons after local elevation of cyclic AMP-dependent activity. J. Cell Biol. 127:1994;1693-1701.